Enrolling by invitationNot applicableNCT06608407
Platelet Rich Plasma in the Prevention of Adhesion Reformation
Studying Asherman syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fu Xing Hospital, Capital Medical University
- Intervention
- PRP group(biological)
- Enrollment
- 46 enrolled
- Eligibility
- 20-40 years · FEMALE
- Timeline
- 2023 – 2025
Study locations (2)
- Fu Xing Hospital, Capital Medical University, Beijing, Beijing Municipality, China
- Fuxing hospital, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06608407 on ClinicalTrials.govOther trials for Asherman syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT05343572Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal EndometriumHugh Taylor
- ACTIVE NOT RECRUITINGNANCT04963179PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.Womed
- RECRUITINGPHASE4NCT04671914Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.Institute for the Care of Mother and Child, Prague, Czech Republic